Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
第一作者:
Paolo,Alboni
第一单位:
Division of Cardiology, Ospedale Civile, Cento, FE 44042, Italy. p.alboni@ausl.fe.it
作者:
医学主题词
投药, 口服(Administration, Oral);青少年(Adolescent);成年人(Adult);老年人(Aged);门诊医疗(Ambulatory Care);抗心律失常药(Anti-Arrhythmia Agents);心房颤动(Atrial Fibrillation);药物疗法, 联合(Drug Therapy, Combination);氟卡尼(Flecainide);住院(Hospitalization);人类(Humans);输注, 静脉内(Infusions, Intravenous);中年人(Middle Aged);普罗帕酮(Propafenone);自我遵嘱服药(Self Administration);片剂(Tablets);青年人(Young Adult)
DOI
10.1136/hrt.2009.187963
PMID
20350992
发布时间
2013-11-21
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



